Cite

HARVARD Citation

    Chodorge, M. et al. (2018). Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment. Scientific reports. 8 (1), pp. 1-14. [Online]. 
  
Back to record